Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China

BackgroundFew data exist on the immunogenicity and safety of an inactivated enterovirus 71 vaccine (EV71 vaccine) coadministered with trivalent split-virion inactivated influenza vaccine (IIV3) in infants.MethodsThis trial was a phase 4, randomized, controlled trial. Infants aged 6-11 months were el...

Full description

Bibliographic Details
Main Authors: Yaping Chen, Yanhui Xiao, Ying Ye, Feng Jiang, Hanqing He, Linyun Luo, Haiping Chen, Lubin Shi, Qiuyue Mu, Wei Chen, Xue Guo, Min Zhang, Jun Li, Qinghu Guan, Zhiping Chen, Xiaoming Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
coadministration
inactivated enterovirus 71 vaccine
trivalent split-virion inactivated influenza vaccine
immunogenicity
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1080408/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1080408/full

Similar Items